Dong‐Young Noh

Seoul National University — South Korea

Biochemistry, Genetics and Molecular Biology · Life Sciences

71h-index20.8kcitations506works0.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Breast Cancer Treatment Studies(151), Breast Lesions and Carcinomas(81), Cancer Risks and Factors(44), BRCA gene mutations in cancer(40), Cancer Genomics and Diagnostics(34)

Publications498 total

Effectiveness of Multi-Layer Perceptron-Based Binary Classification Neural Network in Detecting Breast Cancer Through Nine Human Serum Protein Markers
Cancers·2025· 1 citedOpen Access
Integrating multi‐ancestry genomic and proteomic data to identify blood risk biomarkers and target proteins for breast cancer genetic risk loci
International Journal of Cancer·2025Open Access
Abstract 2286: Integrating multi-ancestry genomic and proteomic data to identify blood risk biomarkers and target proteins for breast cancer genetic risk loci
Cancer Research·2025
Dietary isoflavone intake among breast cancer survivors and cancer-free women
Nutrition Research and Practice·2025Open Access
Abstract 2438: A retrospective pilot study to validate the utility of proteomic biomarkers in the blood for diagnosis of breast cancer
Cancer Research·2024
Dietary Isoflavone Intake and Breast Cancer Prognosis: A Prospective Analysis and Meta-Analysis
Nutrition and Cancer·2023· 9 cited
Quantifiable peptide library bridges the gap for proteomics based biomarker discovery and validation on breast cancer
Scientific Reports·2023· 14 citedOpen Access
Data from STAT3-RANTES Autocrine Signaling Is Essential for Tamoxifen Resistance in Human Breast Cancer Cells
2023Open Access
Data from Preoperative Serum Levels of Matrix Metalloproteinase-2 (MMP-2) and Survival of Breast Cancer among Korean Women
2023Open Access
Data from Preoperative Serum Levels of Matrix Metalloproteinase-2 (MMP-2) and Survival of Breast Cancer among Korean Women
2023Open Access
Diagnostic accuracy of a three-protein signature in women with suspicious breast lesions: a multicenter prospective trial
Breast Cancer Research·2023· 8 citedOpen Access
Biomarkers in Proteomics
2023
The usefulness of a three-protein signature blood assay (Mastocheck®) for follow-up after breast cancer surgery
Journal of Cancer Research and Clinical Oncology·2022Open Access
A Study on the Improvement of Laws for the Development of National Defense and Space Power: Focused on Space Development Promotion Act
2022
A nomogram for predicting three or more axillary lymph node involvement before breast cancer surgery
Scientific Reports·2022· 3 citedOpen Access
Usefulness of three protein signatures (Mastocheck) for follow-up after breast cancer surgery
Research Square (Research Square)·2022Open Access
Diagnostic performance improvement with combined use of proteomics biomarker assay and breast ultrasound
Breast Cancer Research and Treatment·2022· 3 cited
Diagnostic Performance Improvement with Combined use of Proteomics Biomarker Assay and Breast Ultrasound
2021Open Access
JAK2 regulates paclitaxel resistance in triple negative breast cancers
Journal of Molecular Medicine·2021· 33 cited
Correction: Enhanced anti-tumor activity and cytotoxic effect on cancer stem cell population of metformin-butyrate compared with metformin HCl in breast cancer
Oncotarget·2021· 1 citedOpen Access
page 1 of 25Next →

Frequent Co-authors

Wonshik Han(19), Daehee Kang(13), Keun-Young Yoo(7), Chen‐Yang Shen(6), Woo Kyung Moon(6), Hyeong‐Gon Moon(6), Sue K. Park(6), Sei Hyun Ahn(5), Young Ho Yun(5), Douglas F. Easton(4), Karen A. Pooley(4), Alison M. Dunning(4), Paul D.P. Pharoah(4), Brian E. Henderson(4), Loı̈c Le Marchand(4), Olivia Fletcher(4), Nazneen Rahman(4), Børge G. Nordestgaard(4), Montserrat García‐Closas(4), Jolanta Lissowska(4)